Kezar Life Sciences
Price & Volume
Stats
See more52W Range | $5.20-$10.40 |
Market Cap | $42.8M |
Shares Short | 120,601 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$72.3M |
Diluted EPS | -$13.12 |
News
See moreYahoo Finance • 2 years ago
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 2 years ago
Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
Yahoo Finance • 3 years ago
Kezar Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
About
CEO | Dr. Christopher J. Kirk Ph.D. |
CFO | Mr. Marc L. Belsky CPA |
Address | 4000 Shoreline Court, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 58 |
